Filtros de búsqueda

Lista de obras de

A Phase II Study of Nivolumab in Patients With Advanced Non-small-cell Lung Cancer who Responded to Prior PD-1/L1 Inhibitors: West Japan Oncology Group 9616L (WJOG9616L)

artículo científico publicado en 2018

Chemoradiotherapy for Limited-disease Small-cell Lung Cancer in Elderly Patients Aged 75 Years or Older ⬇️

artículo científico publicado el 5 de diciembre de 2012

Clinical significance of monitoring EGFR mutation in plasma using multiplexed digital PCR in EGFR mutated patients treated with afatinib (West Japan Oncology Group 8114LTR study)

scientific article published on 22 March 2019

Detection of AXL expression in circulating tumor cells of lung cancer patients using an automated microcavity array system

scientific article published on 30 January 2020

Differential efficacy of docetaxel according to non-small cell lung cancer histology and the therapeutic effect of epidermal growth factor receptor tyrosine kinase inhibitors ⬇️

artículo científico publicado el 31 de agosto de 2011

EGFR mutation analysis for prospective patient selection in AURA3 phase III trial of osimertinib versus platinum-pemetrexed in patients with EGFR T790M-positive advanced non-small-cell lung cancer

artículo científico publicado en 2018

Efficacy of Rechallenge Chemotherapy in Patients With Sensitive Relapsed Small Cell Lung Cancer ⬇️

artículo científico publicado el 1 de febrero de 2015

Efficacy of bevacizumab-containing chemotherapy for non-squamous non-small cell lung cancer with bone metastases ⬇️

artículo científico publicado el 27 de marzo de 2013

Exploration of resistance mechanisms for EGFR-TKIs based on plasma analysis by digital PCR and next-generation sequencing

scientific article published on 13 November 2018

Feasibility of postoperative adjuvant chemotherapy of cisplatin plus vinorelbine for completely resected non-small-cell lung cancer: A retrospective study in Japan ⬇️

artículo científico publicado el 27 de octubre de 2012

Furosemide versus mannitol in Japanese patients with thoracic malignancy who received cisplatin-based chemotherapy using short hydration: study protocol for a randomised controlled trial

artículo científico publicado en 2019

Immune-Related Adverse Events by Immune Checkpoint Inhibitors Significantly Predict Durable Efficacy Even in Responders with Advanced Non-Small Cell Lung Cancer

artículo científico publicado en 2019

Intestinal metastasis from non-small-cell lung cancer initially detected by 18F-fluorodeoxyglucose positron emission tomography ⬇️

artículo científico publicado el 27 de noviembre de 2010

Nivolumab Retreatment in Non–Small Cell Lung Cancer Patients Who Responded to Prior Immune Checkpoint Inhibitors and Had ICI-Free Intervals (WJOG9616L)

artículo científico publicado en 2022

Osimertinib in Japanese patients with EGFR T790M mutation-positive advanced non-small cell lung cancer: AURA3 trial

artículo científico publicado en 2018

Plasma screening for the T790M mutation of EGFR and phase 2 study of osimertinib efficacy in plasma T790M-positive non-small cell lung cancer: West Japan Oncology Group 8815L/LPS study

artículo científico publicado en 2020

Predictive and sensitive biomarkers for thyroid dysfunctions during treatment with immune-checkpoint inhibitors

scientific article published on 22 February 2020

Prognostic impact of serum CYFRA 21–1 in patients with advanced lung adenocarcinoma: a retrospective study ⬇️

artículo científico publicado el 23 de julio de 2013

Size-Based Isolation of Circulating Tumor Cells in Lung Cancer Patients Using a Microcavity Array System ⬇️

artículo científico publicado el 28 de junio de 2013

The impact of high PD-L1 expression on the surrogate endpoints and clinical outcomes of anti-PD-1/PD-L1 antibodies in non-small cell lung cancer

scientific article published on 26 December 2018

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda